$2.11
-0.09-4.09%
Pre-Market: 8:06 AM EDT
Comments
Loading...
Rein Therapeutics (RNTX) Forecast
NewsEarningsRein Therapeutics (RNTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Rein Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RNTX | Benzinga
Explore Rein Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RNTX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Rein Therapeutics (RNTX) stock?
You can purchase shares of Rein Therapeutics (NASDAQ:RNTX) through any online brokerage.
Who are Rein Therapeutics (RNTX) competitors?
Other companies in Rein Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO) and CytomX Therapeutics (NASDAQ:CTMX).
What is the forecast, or price target, for Rein Therapeutics (RNTX) stock?
There is no analysis for Rein Therapeutics to provide a consensus price target.
What is the current price for Rein Therapeutics (RNTX)?
The stock price for Rein Therapeutics (NASDAQ: RNTX) is $2.11 last updated February 27, 2025 at 8:06 AM EST.
Does Rein Therapeutics (RNTX) pay a dividend?
There are no upcoming dividends for Rein Therapeutics.
When is Rein Therapeutics (NASDAQ:RNTX) reporting earnings?
Rein Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is Rein Therapeutics (RNTX) going to split?
There is no upcoming split for Rein Therapeutics.
What sector and industry does Rein Therapeutics (RNTX) operate in?
Rein Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.